Iredell News

Section: Iredell News

Iredell Health System Chosen To Host Cancer Clinical Trials

08/26/2014

(Statesville, NC – August 26, 2014) –Iredell Health System has been chosen by the National Cancer Institute (NCI) to be one of the sites to conduct cancer clinical trials and cancer care delivery research studies for the next five years in our community.

The grants are awarded under the NCI Community Oncology Research Program (NCORP), a national network of investigators, cancer care providers, academic institutions, and other organizations that provide care to diverse populations in community-based healthcare practices across the United States.

Iredell Health system is participating in the cancer clinical research through the Southeast Clinical Oncology Research Consortium, Inc. (SCOR) based in Winston-Salem, NC. Iredell Health System has participated in cancer clinical research through membership in the Southeast Cancer Control Consortium, Inc. (SCCC) since 1999. The SCCC was a Community Clinical Oncology Program (CCOP) funded by NCI since 1987 providing access to cancer clinical trials to 18 community hospitals/institutions over a 5 state area (GA, NC, SC, TN, and VA). The SCCC merged with Upstate Carolina CCOP located in Spartanburg, SC to apply for the NCORP grant award. A new organization was funded and will operate under the name of Southeast Clinical Oncology Research Consortium, Inc (SCOR) NCORP. The SCOR received an award of approximately $14.8 million over 5 years and will provide access to cancer clinical research to 23 community hospitals/institutions.

NCORP will design and conduct clinical trials to improve cancer prevention, cancer control, screening, and post-treatment management. The new program will have an expanded portfolio of clinical trials and other studies, including an emphasis on cancer care delivery research. Cancer care delivery research focuses on numerous factors that affect access to medical care such as social, financial, technological, and others.

The NCORP involves 53 grants being awarded. The award falls into three categories: 7 research bases, 34 community sites, and 12 minority/underserved community sites. SCOR is one of the 34 community sites. NCORP replaces two previous NCI community-based clinical research programs: the Community Clinical Oncology Program (CCOP) and the NCI Community Cancer Centers Program (NCCCP).

Iredell Health System participating physicians include Ruby Grimm, serving as principle investigator and Naga Jyothi Gavini, Gayla Lowery and Pam Westmoreland Sholar as co-investigators. For more information, contact Beth Deuel, RN Clinical Trial Coordinator at Iredell Health System.

Categories: General News